Spinning Clinical Trials
Reports from clinical trials for breast cancer drugs are often rife with bias and spin, according to a study published this week (January 9) in Annals of Oncology.
Researchers from the University of Toronto analyzed the publications from 164 randomized Phase III clinical trials and found that a third were reported positively despite not meeting the primary objective, by emphasizing other, less important outcomes.
Posted by Joseph Hany
Recent posts
-
Painkillers reduce risks of skin cancer
29 May 2012 -
Young cannabis inhalers going through IQ risks
28 August 2012 -
Aerobic exercise a way to loosen your belly fat
04 September 2012 -
Women dies due to dengue fever in Karachi
06 September 2012 -
People living in country side are more likely to go through Alzheimer's disease
19 September 2012 -
A warning given by WHO on spread of drug resistant malaria to Burma, Vietnam
01 October 2012